Update on Conventional Osteosarcoma
Author Information
Author(s): Teixeira Luiz Eduardo Moreira, Guedes Alex, Nakagawa Suely Akiko, Fonseca Karine Corrêa, Lima Eduardo Ribeiro
Conclusion
Recent advances in oncology have improved survival rates and limb preservation for patients with conventional osteosarcoma.
Supporting Evidence
- Osteosarcoma is the most common bone sarcoma, with a bimodal age distribution.
- Recent studies show a steady increase in 5-year survival rates for children aged 0 to 9.
- Incidence of osteosarcoma relapses has tripled since the 2000s in patients aged 0 to 24.
- Conventional osteosarcoma primarily affects the metaphysis of long bones.
Takeaway
Conventional osteosarcoma is a serious bone cancer that mostly affects kids and teens, but new treatments are helping more people survive and keep their limbs.
Limitations
The study mentions a lack of epidemiological studies on osteosarcoma in Brazil and the rarity of the disease limits demographic studies.
Participant Demographics
The study discusses various demographics, including age ranges from 6 to 78 years, with a slight male predominance and a higher incidence in non-white populations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website